Plasma circulating tumor DNA assessment reveals KMT2D as a potential poor prognostic factor in extranodal NK/T-cell lymphoma.
Li Q, Zhang W, Li J, Xiong J, Liu J, Chen T, Wen Q, Zeng Y, Gao L, Gao L, Zhang C, Kong P, Peng X, Liu Y, Zhang X, Rao J.
Li Q, et al. Among authors: zeng y.
Biomark Res. 2020 Jul 17;8:27. doi: 10.1186/s40364-020-00205-4. eCollection 2020.
Biomark Res. 2020.
PMID: 32695399
Free PMC article.